This topic contains a solution. Click here to go to the answer

Author Question: If a key competitor had a market share of 25 percent and the firm in question had a market share of ... (Read 81 times)

rlane42

  • Hero Member
  • *****
  • Posts: 594
If a key competitor had a market share of 25 percent and the firm in question had a market share of 20 percent, then next year's market share objective should be between 20 and 25 percent. This is an example of which of the following factors?
 a. industry average c. past market share of key competitors
  b. forecasted market share d. None of the above.

Question 2

Which of the following is comparable competitors?
 a. bad model c. opposite model
  b. role model d. None of the above.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

parker125

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

C
Key competitors can be looked at as role models to be emulated in most respects.

Answer to Question 2

B
Comparable competitors may be looked at as role models to be emulated in most respects.




rlane42

  • Member
  • Posts: 594
Reply 2 on: Jun 29, 2018
Gracias!


meow1234

  • Member
  • Posts: 333
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

The Babylonians wrote numbers in a system that used 60 as the base value rather than the number 10. They did not have a symbol for "zero."

Did you know?

According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library